HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls

Huina Zhang1, Brian S Finkelman1, Mark G Ettel1

  • 1Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA.

Histopathology
|March 5, 2024
PubMed
Summary

Accurate human epidermal growth factor receptor 2 (HER2) testing is vital for selecting patients for HER2-targeted therapies. This review details key considerations for HER2 evaluation in various solid tumors to ensure effective treatment decisions.